(By Balachander) DaVita HealthCare Partners Inc. (NYSE: DVA) said its kidney care division has agreed to provide certain pharmacy services to Fresenius Medical Care (FMC).
FMC, which offers dialysis services, will use DaVita Rx prescription drug services for its Medicare patients in the United States.
Congress required that beginning in 2011, some oral medications will be included in the bundled payment model. By 2016 all oral end stage renal disease medications will be included in the bundled payment.
FMC's contract with DaVita Rx will help implement that requirement by using DaVita Rx's pharmacy to fill and ship oral medications to FMC Medicare patients.
[Related -Japan Surges Near 5-Year Highs]
DaVita Rx pharmacy services for FMC will begin in late 2013.
In addition, DaVita said it will be extending its long-standing vendor relationship with FMC for certain dialysis supplies including hemodialysis machines and disposable products.
DaVita Rx has served the prescription drug needs of patients receiving dialysis from DaVita and other dialysis providers since 2005.
On Tuesday, DVA shares rose 0.76 percent to trade at $109.11.